Breaking News

Alphora Completes R&D Cyto-Lab

Expands by 50%

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Alphora has completed a cytotoxics R&D lab, as part of an on-going $4 million capital program for 2011. The program also includes additions to R&D, GMP operations, analytical services and staffing.   The R&D lab is designed to handle high potency active pharmaceutical ingredients (HPAPIs) and class four compounds. It’s equipped with three hard enclosure isolator units, pressure lock entryways and dedicated class HEPA filtered air handling systems.   Alphora’s R&D has been expande...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters